Report
Christophe-Raphaël Ganet

Boiron : OPA (suite) : comité ad hoc désigné

>Comité ad hoc désigné (composé du comité d’audit+1 expert indépendant) - Dans la cadre du projet d’Offre Publique d’Achat simplifiée déposé par Boiron Développement et EW Healthcare Partners, le comité d’expert ad hoc a été désigné. Il s’agit du comité d’audit + un expert indépendant, à nommer prochainement. En principe, le processus de consultation des représentants des salariés devrait durer jusqu’à fin septembre, et le dépôt d’une Offre interviendrait mi ou fin oc...
Underlying
Boiron SA

Boiron manufactures and markets homeopathic medicines. Homeopathic medicines are prepared from vegetable, animal, mineral, or chemical substances, which are diluted. Co. sells three types of products in 59 countries: Non-proprietary homeopathic medicines, OTC family medication specialties, and Other products. There are two large families of homeopathic medicines: Those associated with precise therapeutic indications and dosage, and those that do not mention a therapeutic indication or dosage. Co. supports homeopathy education and training organizations for healthcare professionals. Some of Co.'s brand names include Oscillococcinum®, Stodal®, S?datif PC®, and Coryzalia.

Provider
Oddo BHF
Oddo BHF

​Oddo Securities provides securities brokerage and research services. The company offers equity, economic, and derivatives research and credit analysis services. It focuses on insurance, automotive, building materials, pharmaceuticals, telecommunications, information technology, and agri-food industries.

Analysts
Christophe-Raphaël Ganet

Other Reports on these Companies
Other Reports from Oddo BHF

ResearchPool Subscriptions

Get the most out of your insights

Get in touch